Calcium channels and their role in regenerative medicine

Table 3 Stem cell transplantation therapy in disease

SCT	SCT therapy in preclinical condition
BMCs	Myelofibrosis[116]
HSCs	Fanconi anemia[117], chronic granulomatous disease[118], and Friedreich's ataxia[119]
MAPCs	Myocardial infarction[120], and neonatal hypoxic-ischemic injury[121]
MSCs	Musculoskeletal disease[122], spinal cord injury[123], liver fibrosis[124], idiopathic pneumonia syndrome[125], Alzheimer’s disease[126], and Parkinson's disease[127]
	SCT therapy in clinical condition
BMCs	Post-myocardial infarction[128], and sickle cell diseases[129]
HSCs	Sickle cell disease[130], human cytomegalovirus infection[131], childhood acute t-lymphoblastic leukemia[132], ankylosing spondylitis autoimmune disease[133], Crohn's disease[134], SARS-CoV-2[135], refractory lupus nephritis[136], Pemphigus disease[137], Richter syndrome[138]
MAPCs	Parkinson’s disease[139]
MSCs	Graft vs host disease[140], diabetes mellitus type 2[86], spinal cord injury[141], SARS-CoV-2[142], multiple sclerosis[143], systemic lupus erythematous[144]

BMCs: Bone marrow cells; HSCs: Hematopoietic stem cells; MAPCs: Multipotent adult progenitor stem cells; MSCs: Mesenchymal stem cells; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; SCT: Stem cell transplantation.